Quezada-Chavarría G, Ramírez-Serrallonga R, Quezada-Cuevas SE, Salazar-Salas J, Fernández-Gómez I, Esparza-Pérez RI

Language: Spanish
References: 27
Page: 61-64
PDF size: 29.22 Kb.

ABSTRACT

Background: the Kawasaki disease (EK) is frequently identified in the pediatric age. It affects principally the coronary arteries, causing aneurysms, ischemic heart disease and sudden death. The opportune diagnosis and its early treatment avoid these complications. Our objective was to describe 17 cases with EK
Clinical cases: seventeen patients’ files with EK were reviewed, obtaining information about age, sex, date of admission, clinical manifestations, laboratory results, complications and treatment.
Results: four patients presented coronary aneurysm. The average age was 37 months, with a range from 15 months to 11 years. There was predominance in males, with relation 2.4 to 1.
Conclusions: the EK was not considerated initially; on post-mortem studies affected coronary arteries were demonstrated. The EK treatment is intravenous gamma globulin and aspirin and it must be established before the tenth day after the fever begins, in order to avoid cardiac complications. Four cases that developed AC remitted after 16 months. The EK diagnosis is predominantly clinical.

REFERENCES

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16(3):178-222.

2. Kato H, Hichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease Clinical analysis of 195 cases. J Pediatr 1986;108(6):923-927.

3. Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol 1986;7(1):3-9.

4. Rowley AH, González-Crussi F, Shulman ST. Kawasaki syndrome. Rev Infect Dis 1988;10(1):1-15.

5. Rodríguez-Suárez R. Síndrome linfomucocutáneo. Presentación de un caso. Bol Med Hosp Infant Mex 1977;34:53-57.

6. Vizcaíno-Alarcón A, Arévalo-Salas A, Rodríguez-López AM, Sadowinsky-Pine S. Enfermedad de Kawasaki en niños mexicanos. Bol Med Hosp Infant Mex 1991;48(6):398-408.

7. González-Galnares M, Urbán-Vázquez H, Santamaría-Díaz H, Gorbea-Robles MC. Enfermedad de Kawasaki en México: análisis de 13 casos. Bol Med Hosp Infant Mex 1991;48(6):409-416.

8. Sotelo-Cruz N, González-Ramos LA, Gómez-Rivera N, Manzo-Ríos MA. Enfermedad de Kawasaki. Experiencia en siete niños Rev Mex Pediatr 2001;68(5):189-195.

9. Newburger JW. Kawasaki disease: Who is a risk? J Pediatr 2000;137(2):149-152.

10. Nakamura Y, Fujita Y, Nagai M, Yanagawa H, Imada Y, Okawa S, et al. Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. Pediatrics 1991;88(6):1144-1147.

11. Falcini F. Kawasaki disease. Curr Opin Rheumatol 2006;18(1):33-38.

12. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110(7):2747-2771.

13. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet 1986;2(8506):545-546.

14. Burns JC, Joffe I, Sargent RA, Glode MP. Anterior uveitis associated with Kawasaki syndrome. Pediatr Infect Dis 1985;4(3):258-261.

15. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Cheng KJ, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 1991;324:1633-1639.

16. Shulman ST. Enfermedad de Kawasaki. Bol Med Hosp Infant Mex 1991;48(6):383-384.

17. Tanaka N, Nace S, Kawasaki T. Pathological study on autopsy cases of MCLS. Japan Red Cross Central Hospital 1971;2:85-94

18. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease: a 10-to-20 year follow-up study of 594 patients. Circulation 1996;94(6):1379-1385.

19. Meyer RA. Echocardiography in Kawasaki disease. J Am Soc Echocardiogr 1989;2(4):269-275.

20. Vargas-Barrón J, Andrade-Freire A, Attie F. Diagnóstico con ecocardiografía bidimensional y Doppler de aneurisma coronario en un niño mexicano con enfermedad de Kawasaki. Arch Inst Cardiol Mex 1988;58(3):227-229.

21. Crowley DC. Complicaciones cardiovasculares del síndrome ganglionar mucocutáneo. Clin Pediatr Norteam 1984;6:1335-1344.

22. Hiraishi S, Yashiro K, Oguchi K, Kusano S, Ishii K, Nakasawa K. Clinical course of cardiovascular involvement in the lymph node syndrome. Relation between clinical signs of carditis and development of coronary arterial aneurysm. Am J Cardiol 1981; 47(2):323-330.

23. Takahashi M, Mason W, Lewis AB. Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 1987;75(2):387-394.

24. Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 2001;107(5): 1095-1099.

25. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki Disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;89 (2):916-922.

26. Jacobs JC. Kawasi disease. Curr Opin Rheumatol 1996;8:41-43.

27. Coronel-Rodríguez W, Tello GI, Erdmenger- Orellana J, Coria-Lorenzo JJ. Gómez-Barreto D, Síndrome de Kawasaki. Paciente de menor edad reportado en la casuística del Hospital Infantil de México “Federico Gómez”. Bol Med Hosp Infant Mex 2002;59(7):430-436.